Age-differentiated medication strategy and risk management of maropitant citrate for canine parvovirus infection in puppies
Zhao Yicheng
Zhang Xiaomiao
Dao Anhui
Lai Hui
Li Jie
Yang Hongjuan
Wang Rui
Abstract：The article aims to explore the age-specific dosing strategies and risk control measures of citrulline maropitant for puppies infected with parvovirus,in order to improve the treatment effect and ensure the health of puppies.Due to the differences in organ development and metabolic capacity among dogs of different ages,their pharmacokinetic profiles of citrulline maropitant vary.Therefore,differentiated dosing regimens,frequencies,and treatment courses need to be established.At the same time,establishing a drug adverse reaction monitoring system,strengthening medication guidance and training,and formulating treatment effect evaluation standards are all crucial risk control measures that can significantly reduce treatment risks.The article comprehensively analyzed the physiological characteristics,pharmacokinetic data,and clinical experience of young dogs,and formulated treatment plans for puppies infected with parvovirus at different age stages,with the aim of provide a reference for the precise treatment of parvovirus infection in puppies.
Keywords：PuppyCanine parvovirusMaropitant citrateAge-differentiated medication
Publication Date：2026-02-15
Online Publishing Date：2026-03-16(First online date of this platform, not the publication date of the document)
Pages：4( 93-96 )